{"id":1041630,"date":"2024-07-15T02:35:41","date_gmt":"2024-07-15T06:35:41","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/lexeo-therapeutics-announces-investor-webcast-to-report-interim-phase-1-2-clinical-data-of-lx2006-for-the-treatment-of-friedreich-ataxia\/"},"modified":"2024-08-17T16:50:37","modified_gmt":"2024-08-17T20:50:37","slug":"lexeo-therapeutics-announces-investor-webcast-to-report-interim-phase-1-2-clinical-data-of-lx2006-for-the-treatment-of-friedreich-ataxia","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/lexeo-therapeutics-announces-investor-webcast-to-report-interim-phase-1-2-clinical-data-of-lx2006-for-the-treatment-of-friedreich-ataxia.php","title":{"rendered":"Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1\/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia&#8230;"},"content":{"rendered":"<p><![CDATA[NEW YORK, July  11, 2024  (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer\u2019s disease, today announced that the company will conduct an investor webcast on Monday, July 15, 2024, at 8:00 AM ET to provide an interim clinical data update on LX2006, an AAVrh10.hFXN gene therapy for the treatment of Friedreich ataxia (FA) cardiomyopathy. The presentation will include an overview of the natural history of FA cardiomyopathy and summary of clinically meaningful endpoints, interim data from Lexeo\u2019s ongoing SUNRISE-FA Phase 1\/2 clinical trial (NCT05445323) and the ongoing Weill Cornell Medicine investigator-initiated trial (NCT05302271), as well as an overview of program next steps.]]><\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/07\/11\/2911772\/0\/en\/Lexeo-Therapeutics-Announces-Investor-Webcast-to-Report-Interim-Phase-1-2-Clinical-Data-of-LX2006-for-the-Treatment-of-Friedreich-Ataxia-Cardiomyopathy-on-Monday-July-15-2024.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1\/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia...\" rel=\"noopener\">Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1\/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>More here: Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1\/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/lexeo-therapeutics-announces-investor-webcast-to-report-interim-phase-1-2-clinical-data-of-lx2006-for-the-treatment-of-friedreich-ataxia.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-1041630","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1041630"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1041630"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1041630\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1041630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1041630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1041630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}